AI Article Synopsis

  • Researchers developed long-acting forms of gut hormones GIP, xenin, and oxytomodulin that positively impact diabetes control and pancreatic health.
  • In a study using diabetic mice, these hormones improved pancreatic insulin content and altered pancreatic morphology without significantly changing body weight or blood glucose levels.
  • The treatment was linked to increased conversion of alpha-cells to insulin-producing beta-cells and reduced alpha-cell identity, suggesting a potential mechanism for restoring beta-cell function in diabetes.

Article Abstract

Enzyme-resistant long-acting forms of the gut-derived peptide hormones, glucose-dependent insulinotropic polypeptide (GIP), xenin and oxyntomodulin (Oxm) have been generated, and exert beneficial effects on diabetes control and pancreatic islet architecture. The current study has employed alpha-cell lineage tracing in Glu;ROSA26-eYFP transgenic mice to investigate the extent to which these positive pancreatic effects are associated with alpha- to beta-cell transdifferentiation. Twice-daily administration of (D-Ala)GIP, xenin-25[LysPAL] or (D-Ser)-Oxm[LysPAL] for 10 days to streptozotocin (STZ)-induced diabetic mice did not affect body weight, food intake or blood glucose levels, but (D-Ser)-Oxm[LysPAL] reduced (P < 0.05 to P < 0.001) fluid intake and circulating glucagon. (D-Ala)GIP and (D-Ser)-Oxm[LysPAL] also augmented (P < 0.05 and P < 0.01, respectively) pancreatic insulin content. Detrimental changes of pancreatic morphology induced by STZ in Glu;ROSA26-eYFP mice were partially reversed by all treatment interventions. This was associated with reduced (P < 0.05) apoptosis and increased (P < 0.05 to P < 0.01) proliferation of beta-cells, alongside opposing effects on alpha-cells, with (D-Ala)GIP and (D-Ser)-Oxm[LysPAL] being particularly effective in this regard. Alpha-cell lineage tracing revealed that induction of diabetes was accompanied by increased (P < 0.01) transdifferentiation of glucagon positive alpha-cells to insulin positive beta-cells. This islet cell transitioning process was augmented (P < 0.01 and P < 0.001, respectively) by (D-Ala)GIP and (D-Ser)-Oxm[LysPAL]. (D-Ser)-Oxm[LysPAL] also significantly (P < 0.05) promoted loss of alpha-cell identity in favour of other endocrine islet cells. These data highlight intra-islet benefits of (D-Ala)GIP, xenin-25[LysPAL] and (D-Ser)-Oxm[LysPAL] in diabetes with beta-cell loss induced by STZ. The effects appear to be independent of glycaemic change, and associated with alpha- to beta-cell transdifferentiation for the GIP and Oxm analogues.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212078PMC
http://dx.doi.org/10.1016/j.peptides.2019.170205DOI Listing

Publication Analysis

Top Keywords

gip xenin
8
xenin oxyntomodulin
8
effects long-acting
4
long-acting gip
4
oxyntomodulin peptide
4
peptide analogues
4
analogues alpha-cell
4
alpha-cell transdifferentiation
4
transdifferentiation insulin-deficient
4
insulin-deficient diabetic
4

Similar Publications

Maternal serum xenin-25 levels in gestational diabetes mellitus.

Eur Rev Med Pharmacol Sci

October 2023

Department of Obstetrics and Gynecology, Perinatology Division, Kocaeli City Hospital, Kocaeli, Turkey.

Objective: Xenin-25 is a polypeptide having an insulinotropic effect via increasing the insulin-releasing action of glucose-dependent insulinotropic polypeptide (GIP) and promoting beta cell survival and proliferation. We aimed to assess serum xenin-25 levels in euglycemic pregnancies vs. pregnancies complicated with gestational diabetes mellitus (GDM).

View Article and Find Full Text PDF

Xenin and Related Peptides: Potential Therapeutic Role in Diabetes and Related Metabolic Disorders.

Clin Med Insights Endocrinol Diabetes

September 2021

Faculty of Life and Health Sciences, School of Biomedical Sciences, Ulster University, UK.

Xenin bioactivity and its role in normal physiology has been investigated by several research groups since its discovery in 1992. The 25 amino acid peptide hormone is secreted from the same enteroendocrine K-cells as the incretin hormone glucose-dependent insulinotropic polypeptide (GIP), with early studies highlighting the biological significance of xenin in the gastrointestinal tract, along with effects on satiety. Recently there has been more focus directed towards the role of xenin in insulin secretion and potential for diabetes therapies, especially through its ability to potentiate the insulinotropic actions of GIP as well as utilisation in dual/triple acting gut hormone therapeutic approaches.

View Article and Find Full Text PDF

Neurotensin and xenin possess antidiabetic potential, mediated in part through augmentation of incretin hormone, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), action. In the present study, fragment peptides of neurotensin and xenin, acetyl-neurotensin and xenin-8-Gln, were fused together to create Ac-NT/XN-8-Gln. Following assessment of enzymatic stability, effects of Ac-NT/XN-8-Gln on in vitro β-cell function were studied.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the effects of the MetAP2 inhibitor TNP-470 on obesity and diabetes when combined with the drug sitagliptin.
  • TNP-470 and sitagliptin were tested in diabetic mice, individually and together, showing improvements in blood glucose levels, insulin response, and body weight reduction.
  • The combination therapy proved to be more effective than each treatment alone, enhancing metabolic benefits and increasing levels of the hormone xenin, which may contribute to the treatment's success.
View Article and Find Full Text PDF

Messenger RNA expression and localization of xenin in the gastrointestinal tract in sheep.

Domest Anim Endocrinol

January 2021

Laboratory of Veterinary Physiology, Division of Biosciences, Department of Veterinary Medicine, School of Veterinary Medicine, Rakuno Gakuen University, 582 Bunkyodai-Midorimachi, Ebetsu, Hokkaido, 069-8501, Japan.

The present study aimed to determine the primary sequence of ovine xenin and clarify the mRNA expression and peptide localization of xenin in the gastrointestinal tract in sheep. The colocalization of xenin and glucose-dependent insulinotropic polypeptide was also compared in the antrum and duodenum. Analysis of the nucleotide sequence of ovine xenin revealed a high degree (97.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!